COMP <GO>
CDNA vs VCYT // GROSS PROFIT MARGIN
CareDx Inc. (NASDAQ) VS. Veracyte Inc. (NASDAQ) • 15-METRIC TALLY: CDNA 1
— VCYT 10
■ METRIC PARITY
LAST: $71.52 (-0.85%) • MKT CAP: $3.70B
gross-margins
—
LAST: $52.17 (+3.70%) • MKT CAP: $4.19B
gross-margins
70.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDNA VS. VCYT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CDNA | VCYT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | 70.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -8.20% | 4.60% | -12.80 | VCYT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 58.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.67% | 3.02% | -2.35 | VCYT | /fcf-yield <GO> |
| Operating Margin | -8.10% | 11.20% | -19.30 | VCYT | /operating-margins <GO> |
| Net Profit Margin | -5.60% | 12.80% | -18.40 | VCYT | /net-margins <GO> |
| Revenue Growth (YoY) | 13.80% | 16.00% | -2.20 | VCYT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 19.22 | 26.00 | -6.78 | VCYT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | VCYT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.9 | 65.5 | -10.60 | VCYT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 1.08 | -0.02 | VCYT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 53.1x | -32.10 | CDNA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.70B | $4.19B | -$494.0M | VCYT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CDNA REV | VCYT REV | CDNA GROSS % | VCYT GROSS % | CDNA FCF | VCYT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $379.8M | $517.1M | — | 70.1% | $24.9M | $126.6M |
| FY 2024 | $333.8M | $445.8M | — | 66.9% | $23.0M | $63.8M |
| FY 2023 | $280.3M | $361.1M | — | — | -$31.0M | $28.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDNA // BETA 1.06
VCYT // BETA 1.08